Loading…
Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats
Induction of dopamine D3 receptor gene expression in 6‐hydroxydopamine‐lesioned rats by repeated administration of levodopa had been suggested to be responsible for behavioural sensitization developing in these animals. Using double in situ hybridization techniques, we show that D3 receptor mRNA ind...
Saved in:
Published in: | The European journal of neuroscience 2000-06, Vol.12 (6), p.2117-2123 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13 |
---|---|
cites | cdi_FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13 |
container_end_page | 2123 |
container_issue | 6 |
container_start_page | 2117 |
container_title | The European journal of neuroscience |
container_volume | 12 |
creator | Bordet, Régis Ridray, Sophie Schwartz, Jean-Charles Sokoloff, Pierre |
description | Induction of dopamine D3 receptor gene expression in 6‐hydroxydopamine‐lesioned rats by repeated administration of levodopa had been suggested to be responsible for behavioural sensitization developing in these animals. Using double in situ hybridization techniques, we show that D3 receptor mRNA induction after repeated administration of levodopa took place mainly in dynorphin/substance P‐expressing neurons of the direct striatonigral pathway. In agreement, induction of D3 receptor binding sites was evidenced, using 7‐[3H]hydroxy‐N,N‐di‐propyl‐2‐aminotetralin ([3H]7‐OH‐DPAT), in substantia nigra pars reticulata, the projection area of the direct nigrostriatonigral pathway. Changes in D3 receptor binding and behavioural sensitization during intermittent administration of levodopa paralleled changes in prodynorphin/preprotachykinin rather than preproenkephalin/prodynorphin and preproenkephalin/preprotachykinin mRNA ratios. Behavioural sensitization, induction of D3 receptor binding and changes in prodynorphin/preprotachykinin ratio were all prevented together when levodopa was continuously delivered or intermittently delivered in combination with r‐(+)‐7‐chloro‐8‐hydroxy‐3‐methyl‐1‐phenyl‐2,3,4,5‐tetrahydro‐1H‐3‐benzazepine (SCH 23390), a selective D1 receptor antagonist. Our results indicate that functional changes of the direct striatal output pathway, possibly through an interaction between D1 and D3 receptors at the level of terminals in the substantia nigra pars reticulata, are important for the development of behavioural sensitization. |
doi_str_mv | 10.1046/j.1460-9568.2000.00089.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20952990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20952990</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13</originalsourceid><addsrcrecordid>eNqNkctu1DAYRi0EokPhFVDEArFJsOP4JrFBozIUlcKiCMTGchKH8ZDYU9uZTnh6nKaqEAvEwvLiP9_nywEgQ7BAsKKvdwWqKMwFobwoIYRFWlwUxwdgdT94CFZQEJxzRL-dgCch7GaIVuQxOEGQc4oJWoF4bg-uP-hB25i5LotbnbXG6yZmIXqjorPmh1d9tldxe6OmzNis1wfXur3KjW3HRrdZ0DaYaH6paJydCZpvp9a74zRjg7E673VIs8R6FcNT8KhTfdDP7vZT8OXd2dX6fX7xaXO-fnuRN4QIkWOOddV0DCFUNko0tGsIhryuy1IxRrVQuBKK6bqqBSlbSOs6Bbqa4E7hukP4FLxcevfeXY86RDmY0Oi-V1a7McgyfVApBEzgq3-CiHFIEBNcJPTFX-jOjd6mZ6S6quSoYvPBfIEa70LwupN7bwblJ4mgnA3KnZxFyVmUnA3KW4PymKLP7_rHetDtH8FFWQLeLMCN6fX038Xy7MMlvL1_vsRNiPp4H1f-p6QMMyK_Xm7kR7S5-sy-C7nGvwGjxLsN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204281471</pqid></control><display><type>article</type><title>Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Bordet, Régis ; Ridray, Sophie ; Schwartz, Jean-Charles ; Sokoloff, Pierre</creator><creatorcontrib>Bordet, Régis ; Ridray, Sophie ; Schwartz, Jean-Charles ; Sokoloff, Pierre</creatorcontrib><description>Induction of dopamine D3 receptor gene expression in 6‐hydroxydopamine‐lesioned rats by repeated administration of levodopa had been suggested to be responsible for behavioural sensitization developing in these animals. Using double in situ hybridization techniques, we show that D3 receptor mRNA induction after repeated administration of levodopa took place mainly in dynorphin/substance P‐expressing neurons of the direct striatonigral pathway. In agreement, induction of D3 receptor binding sites was evidenced, using 7‐[3H]hydroxy‐N,N‐di‐propyl‐2‐aminotetralin ([3H]7‐OH‐DPAT), in substantia nigra pars reticulata, the projection area of the direct nigrostriatonigral pathway. Changes in D3 receptor binding and behavioural sensitization during intermittent administration of levodopa paralleled changes in prodynorphin/preprotachykinin rather than preproenkephalin/prodynorphin and preproenkephalin/preprotachykinin mRNA ratios. Behavioural sensitization, induction of D3 receptor binding and changes in prodynorphin/preprotachykinin ratio were all prevented together when levodopa was continuously delivered or intermittently delivered in combination with r‐(+)‐7‐chloro‐8‐hydroxy‐3‐methyl‐1‐phenyl‐2,3,4,5‐tetrahydro‐1H‐3‐benzazepine (SCH 23390), a selective D1 receptor antagonist. Our results indicate that functional changes of the direct striatal output pathway, possibly through an interaction between D1 and D3 receptors at the level of terminals in the substantia nigra pars reticulata, are important for the development of behavioural sensitization.</description><identifier>ISSN: 0953-816X</identifier><identifier>EISSN: 1460-9568</identifier><identifier>DOI: 10.1046/j.1460-9568.2000.00089.x</identifier><identifier>PMID: 10886351</identifier><identifier>CODEN: EJONEI</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Animals ; Antiparkinson Agents - pharmacology ; Benzazepines - metabolism ; Benzazepines - pharmacology ; Binding, Competitive - physiology ; Corpus Striatum - cytology ; Denervation ; Dizocilpine Maleate - pharmacology ; Dopamine Agonists - metabolism ; Dopamine Agonists - pharmacology ; Dopamine Antagonists - metabolism ; Dopamine Antagonists - pharmacology ; dopamine D3 receptor ; Enkephalins - genetics ; Excitatory Amino Acid Antagonists - pharmacology ; Gene Expression - physiology ; Levodopa - pharmacology ; Male ; Neural Pathways ; Neurons - chemistry ; Neurons - physiology ; Opioid Peptides - metabolism ; Oxidopamine ; Parkinson Disease, Secondary - chemically induced ; Parkinson Disease, Secondary - drug therapy ; Parkinson Disease, Secondary - pathology ; Parkinson's disease ; preprotachykinin ; prodynorphin ; Protein Precursors - genetics ; Rats ; Rats, Wistar ; Receptors, Dopamine D2 - analysis ; Receptors, Dopamine D2 - genetics ; Receptors, Dopamine D3 ; RNA, Messenger - analysis ; Substantia Nigra - cytology ; Sympatholytics ; Tachykinins - genetics ; Tetrahydronaphthalenes - metabolism ; Tetrahydronaphthalenes - pharmacology ; Tritium ; Ventral Tegmental Area - cytology</subject><ispartof>The European journal of neuroscience, 2000-06, Vol.12 (6), p.2117-2123</ispartof><rights>European Neuroscience Association</rights><rights>Copyright Oxford University Press Jun 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13</citedby><cites>FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10886351$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bordet, Régis</creatorcontrib><creatorcontrib>Ridray, Sophie</creatorcontrib><creatorcontrib>Schwartz, Jean-Charles</creatorcontrib><creatorcontrib>Sokoloff, Pierre</creatorcontrib><title>Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats</title><title>The European journal of neuroscience</title><addtitle>Eur J Neurosci</addtitle><description>Induction of dopamine D3 receptor gene expression in 6‐hydroxydopamine‐lesioned rats by repeated administration of levodopa had been suggested to be responsible for behavioural sensitization developing in these animals. Using double in situ hybridization techniques, we show that D3 receptor mRNA induction after repeated administration of levodopa took place mainly in dynorphin/substance P‐expressing neurons of the direct striatonigral pathway. In agreement, induction of D3 receptor binding sites was evidenced, using 7‐[3H]hydroxy‐N,N‐di‐propyl‐2‐aminotetralin ([3H]7‐OH‐DPAT), in substantia nigra pars reticulata, the projection area of the direct nigrostriatonigral pathway. Changes in D3 receptor binding and behavioural sensitization during intermittent administration of levodopa paralleled changes in prodynorphin/preprotachykinin rather than preproenkephalin/prodynorphin and preproenkephalin/preprotachykinin mRNA ratios. Behavioural sensitization, induction of D3 receptor binding and changes in prodynorphin/preprotachykinin ratio were all prevented together when levodopa was continuously delivered or intermittently delivered in combination with r‐(+)‐7‐chloro‐8‐hydroxy‐3‐methyl‐1‐phenyl‐2,3,4,5‐tetrahydro‐1H‐3‐benzazepine (SCH 23390), a selective D1 receptor antagonist. Our results indicate that functional changes of the direct striatal output pathway, possibly through an interaction between D1 and D3 receptors at the level of terminals in the substantia nigra pars reticulata, are important for the development of behavioural sensitization.</description><subject>Animals</subject><subject>Antiparkinson Agents - pharmacology</subject><subject>Benzazepines - metabolism</subject><subject>Benzazepines - pharmacology</subject><subject>Binding, Competitive - physiology</subject><subject>Corpus Striatum - cytology</subject><subject>Denervation</subject><subject>Dizocilpine Maleate - pharmacology</subject><subject>Dopamine Agonists - metabolism</subject><subject>Dopamine Agonists - pharmacology</subject><subject>Dopamine Antagonists - metabolism</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>dopamine D3 receptor</subject><subject>Enkephalins - genetics</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Gene Expression - physiology</subject><subject>Levodopa - pharmacology</subject><subject>Male</subject><subject>Neural Pathways</subject><subject>Neurons - chemistry</subject><subject>Neurons - physiology</subject><subject>Opioid Peptides - metabolism</subject><subject>Oxidopamine</subject><subject>Parkinson Disease, Secondary - chemically induced</subject><subject>Parkinson Disease, Secondary - drug therapy</subject><subject>Parkinson Disease, Secondary - pathology</subject><subject>Parkinson's disease</subject><subject>preprotachykinin</subject><subject>prodynorphin</subject><subject>Protein Precursors - genetics</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Dopamine D2 - analysis</subject><subject>Receptors, Dopamine D2 - genetics</subject><subject>Receptors, Dopamine D3</subject><subject>RNA, Messenger - analysis</subject><subject>Substantia Nigra - cytology</subject><subject>Sympatholytics</subject><subject>Tachykinins - genetics</subject><subject>Tetrahydronaphthalenes - metabolism</subject><subject>Tetrahydronaphthalenes - pharmacology</subject><subject>Tritium</subject><subject>Ventral Tegmental Area - cytology</subject><issn>0953-816X</issn><issn>1460-9568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqNkctu1DAYRi0EokPhFVDEArFJsOP4JrFBozIUlcKiCMTGchKH8ZDYU9uZTnh6nKaqEAvEwvLiP9_nywEgQ7BAsKKvdwWqKMwFobwoIYRFWlwUxwdgdT94CFZQEJxzRL-dgCch7GaIVuQxOEGQc4oJWoF4bg-uP-hB25i5LotbnbXG6yZmIXqjorPmh1d9tldxe6OmzNis1wfXur3KjW3HRrdZ0DaYaH6paJydCZpvp9a74zRjg7E673VIs8R6FcNT8KhTfdDP7vZT8OXd2dX6fX7xaXO-fnuRN4QIkWOOddV0DCFUNko0tGsIhryuy1IxRrVQuBKK6bqqBSlbSOs6Bbqa4E7hukP4FLxcevfeXY86RDmY0Oi-V1a7McgyfVApBEzgq3-CiHFIEBNcJPTFX-jOjd6mZ6S6quSoYvPBfIEa70LwupN7bwblJ4mgnA3KnZxFyVmUnA3KW4PymKLP7_rHetDtH8FFWQLeLMCN6fX038Xy7MMlvL1_vsRNiPp4H1f-p6QMMyK_Xm7kR7S5-sy-C7nGvwGjxLsN</recordid><startdate>200006</startdate><enddate>200006</enddate><creator>Bordet, Régis</creator><creator>Ridray, Sophie</creator><creator>Schwartz, Jean-Charles</creator><creator>Sokoloff, Pierre</creator><general>Blackwell Science Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>200006</creationdate><title>Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats</title><author>Bordet, Régis ; Ridray, Sophie ; Schwartz, Jean-Charles ; Sokoloff, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Antiparkinson Agents - pharmacology</topic><topic>Benzazepines - metabolism</topic><topic>Benzazepines - pharmacology</topic><topic>Binding, Competitive - physiology</topic><topic>Corpus Striatum - cytology</topic><topic>Denervation</topic><topic>Dizocilpine Maleate - pharmacology</topic><topic>Dopamine Agonists - metabolism</topic><topic>Dopamine Agonists - pharmacology</topic><topic>Dopamine Antagonists - metabolism</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>dopamine D3 receptor</topic><topic>Enkephalins - genetics</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Gene Expression - physiology</topic><topic>Levodopa - pharmacology</topic><topic>Male</topic><topic>Neural Pathways</topic><topic>Neurons - chemistry</topic><topic>Neurons - physiology</topic><topic>Opioid Peptides - metabolism</topic><topic>Oxidopamine</topic><topic>Parkinson Disease, Secondary - chemically induced</topic><topic>Parkinson Disease, Secondary - drug therapy</topic><topic>Parkinson Disease, Secondary - pathology</topic><topic>Parkinson's disease</topic><topic>preprotachykinin</topic><topic>prodynorphin</topic><topic>Protein Precursors - genetics</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Dopamine D2 - analysis</topic><topic>Receptors, Dopamine D2 - genetics</topic><topic>Receptors, Dopamine D3</topic><topic>RNA, Messenger - analysis</topic><topic>Substantia Nigra - cytology</topic><topic>Sympatholytics</topic><topic>Tachykinins - genetics</topic><topic>Tetrahydronaphthalenes - metabolism</topic><topic>Tetrahydronaphthalenes - pharmacology</topic><topic>Tritium</topic><topic>Ventral Tegmental Area - cytology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bordet, Régis</creatorcontrib><creatorcontrib>Ridray, Sophie</creatorcontrib><creatorcontrib>Schwartz, Jean-Charles</creatorcontrib><creatorcontrib>Sokoloff, Pierre</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>The European journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bordet, Régis</au><au>Ridray, Sophie</au><au>Schwartz, Jean-Charles</au><au>Sokoloff, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats</atitle><jtitle>The European journal of neuroscience</jtitle><addtitle>Eur J Neurosci</addtitle><date>2000-06</date><risdate>2000</risdate><volume>12</volume><issue>6</issue><spage>2117</spage><epage>2123</epage><pages>2117-2123</pages><issn>0953-816X</issn><eissn>1460-9568</eissn><coden>EJONEI</coden><abstract>Induction of dopamine D3 receptor gene expression in 6‐hydroxydopamine‐lesioned rats by repeated administration of levodopa had been suggested to be responsible for behavioural sensitization developing in these animals. Using double in situ hybridization techniques, we show that D3 receptor mRNA induction after repeated administration of levodopa took place mainly in dynorphin/substance P‐expressing neurons of the direct striatonigral pathway. In agreement, induction of D3 receptor binding sites was evidenced, using 7‐[3H]hydroxy‐N,N‐di‐propyl‐2‐aminotetralin ([3H]7‐OH‐DPAT), in substantia nigra pars reticulata, the projection area of the direct nigrostriatonigral pathway. Changes in D3 receptor binding and behavioural sensitization during intermittent administration of levodopa paralleled changes in prodynorphin/preprotachykinin rather than preproenkephalin/prodynorphin and preproenkephalin/preprotachykinin mRNA ratios. Behavioural sensitization, induction of D3 receptor binding and changes in prodynorphin/preprotachykinin ratio were all prevented together when levodopa was continuously delivered or intermittently delivered in combination with r‐(+)‐7‐chloro‐8‐hydroxy‐3‐methyl‐1‐phenyl‐2,3,4,5‐tetrahydro‐1H‐3‐benzazepine (SCH 23390), a selective D1 receptor antagonist. Our results indicate that functional changes of the direct striatal output pathway, possibly through an interaction between D1 and D3 receptors at the level of terminals in the substantia nigra pars reticulata, are important for the development of behavioural sensitization.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>10886351</pmid><doi>10.1046/j.1460-9568.2000.00089.x</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0953-816X |
ispartof | The European journal of neuroscience, 2000-06, Vol.12 (6), p.2117-2123 |
issn | 0953-816X 1460-9568 |
language | eng |
recordid | cdi_proquest_miscellaneous_20952990 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Animals Antiparkinson Agents - pharmacology Benzazepines - metabolism Benzazepines - pharmacology Binding, Competitive - physiology Corpus Striatum - cytology Denervation Dizocilpine Maleate - pharmacology Dopamine Agonists - metabolism Dopamine Agonists - pharmacology Dopamine Antagonists - metabolism Dopamine Antagonists - pharmacology dopamine D3 receptor Enkephalins - genetics Excitatory Amino Acid Antagonists - pharmacology Gene Expression - physiology Levodopa - pharmacology Male Neural Pathways Neurons - chemistry Neurons - physiology Opioid Peptides - metabolism Oxidopamine Parkinson Disease, Secondary - chemically induced Parkinson Disease, Secondary - drug therapy Parkinson Disease, Secondary - pathology Parkinson's disease preprotachykinin prodynorphin Protein Precursors - genetics Rats Rats, Wistar Receptors, Dopamine D2 - analysis Receptors, Dopamine D2 - genetics Receptors, Dopamine D3 RNA, Messenger - analysis Substantia Nigra - cytology Sympatholytics Tachykinins - genetics Tetrahydronaphthalenes - metabolism Tetrahydronaphthalenes - pharmacology Tritium Ventral Tegmental Area - cytology |
title | Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T19%3A29%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Involvement%20of%20the%20direct%20striatonigral%20pathway%20in%20levodopa-induced%20sensitization%20in%206-hydroxydopamine-lesioned%20rats&rft.jtitle=The%20European%20journal%20of%20neuroscience&rft.au=Bordet,%20R%C3%A9gis&rft.date=2000-06&rft.volume=12&rft.issue=6&rft.spage=2117&rft.epage=2123&rft.pages=2117-2123&rft.issn=0953-816X&rft.eissn=1460-9568&rft.coden=EJONEI&rft_id=info:doi/10.1046/j.1460-9568.2000.00089.x&rft_dat=%3Cproquest_cross%3E20952990%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5599-383e4cf71112ca9c6fc5308bb22a776e9a349a7eb4b952d06bb3e4fb53fa3bf13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=204281471&rft_id=info:pmid/10886351&rfr_iscdi=true |